SCHEMBL9714488

SCHEMBL9714488

CC(C#N)Cc1ccc(CCl)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.36
TDP1 Q9NUW8 2/20 0.36
MAOB P27338 1/20 0.36
CYP2D6 P10635 3/20 0.35
TAAR1 Q96RJ0 4/20 0.33
SLC6A4 P31645 3/20 0.33
SLC6A2 P23975 2/20 0.33
SIGMAR1 Q99720 2/20 0.33
MAOA P21397 1/20 0.33
SLC6A3 Q01959 1/20 0.33
CYP2A6 P11509 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
SLC18A2 Q05940 1/20 0.32
CYP1A2 P05177 2/20 0.31
TSHR P16473 1/20 0.31
TRPA1 O75762 1/20 0.31
ESR1 P03372 1/20 0.31
ESR2 Q92731 1/20 0.31
CTSH P09668 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9714816 0.87 SLC6A2 (0.34) CYP3A4TDP1MAOBTAAR1SLC6A4
SCHEMBL9714829 0.85 CYP3A4 (0.34) CYP3A4TDP1TSHRCTSC
SCHEMBL9714707 0.82 CYP3A4 (0.34) CYP3A4TDP1MAOBCYP2D6CYP1A2
SCHEMBL9714774 0.82 CYP3A4 (0.36) CYP3A4TDP1TSHRTRPA1ESR1
SCHEMBL9714791 0.80 LTA4H (0.36) TDP1MAOBSIGMAR1
SCHEMBL14452762 0.78 SIGMAR1 (0.52) CYP3A4TDP1MAOBCYP2D6TAAR1
SCHEMBL1752148 0.78 SIGMAR1 (0.52) CYP3A4TDP1MAOBCYP2D6TAAR1
SCHEMBL13593628 0.78 SIGMAR1 (0.52) CYP3A4TDP1MAOBCYP2D6TAAR1
SCHEMBL9714601 0.77 ESR2 (0.36) CYP3A4TDP1CYP1A2ESR1ESR2
SCHEMBL9714646 0.76 MEN1 (0.35) CYP3A4TDP1TSHRCTSC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5166210-A QUINOLINE DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D4 RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1992-11-24 US disclosed
US-5028615-A Treatment of hypersensitivity RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1991-07-02 US disclosed
US-4920133-A Quinoline derivatives and use thereof as antagonists of leukotriene D4 RORER PHARMACEUTICAL CORP. (US) 1990-04-24 US disclosed